DASHENLIN PHARMACEUTICAL GROUP CO L revenue breakdown overview

DASHENLIN PHARMACEUTICAL GROUP CO L revenue for the last year amounted to 26.50 B CNY, the most of which — 21.92 B CNY — came from its highest performing source at the moment, Retail, the year earlier bringing 20.51 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought DASHENLIN PHARMACEUTICAL GROUP CO L 26.50 B CNY, and the year before that — 24.53 B CNY.